Clinical Trials Browser

Phase 1/2 × Oropharyngeal Neoplasms × Specimen Handling × Clear all

NCT05232851 2026-02-10

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Phase 1/2 Completed

Carcinoma, Oropharyngeal Neoplasms